(3) | The amounts shown in this column in respect of 2020, 2019 and 2018 represent the grant date fair value, as determined in accordance with ASC 718, of time-based RSUs awarded on February 26, 2020, March 15, 2019 and March 9, 2018 in the amounts of: (16,071, 22,195, and 21,174 for Mr. Spector; 8,207, 11,097, and 10,587 for Mr. Jones; 6,423, 8,998 and 8,469 for Mr. Fartaj; 6,423, 8,909, 8,469 for Mr. Chang, respectively; and 4,817 for Mr. Grogin on February 26, 2020. Also includes the grant date fair value, as determined in accordance with ASC 718, of the (a) performance-based RSUs awarded on February 26, 2020, March 15, 2019 and March 9, 2018 in the amounts of 32,143, 44,390 and 42,348 for Mr. Spector; 16,414, 22,195 and 21,174 for Mr. Jones; 12,846, 17,997 and 16,939 for Mr. Fartaj; 12,846, 17,819 and 16,939 for Mr. Chang; and 9,634 for Mr. Grogin, respectively, pursuant to our 2013 Plan. See “—2020 Outstanding Equity Awards at Fiscal Year-End” below. Such aggregate grant date fair values do not take into account any estimated forfeitures related to service vesting conditions. For more information on the assumptions used in our estimates of value, please refer to Note 20—Stock-based Compensation in our Annual Report on Form 10-K filed on February 25, 2021. The value of the performance-based RSUs awarded on February 26, 2020, March 15, 2019 and March 9, 2018, assuming that the highest level of performance conditions will be achieved and based on a grant date fair value per share of $35.03, $22.92 and $24.40, is $2,111,188, $1,322,644 and $1,343,269 for Mr. Spector; $1,078,083, $661,311 and $671,634 for Mr. Jones; $843,733, $536,236 and $537,288 for Mr. Fartaj, and $843,733, $530,919 and $537,288 for Mr. Chang; and $632,747 for Mr. Grogin, respectively. The amounts reported in this column reflect the accounting cost for these RSUs and do not correspond to the actual economic value that may be received by upon vesting and/or settlement of the RSUs. |